Pune, India -- (SBWIRE) -- 04/22/2019 -- The Global Cardiovascular and Soft Tissue Repair Patches Market is forecasted to grow at a stable CAGR around 8% during the forecast period and reach around US$ 6 billion by 2026.

One of the main drivers of the market is the increasing prevalence of cardiovascular diseases (CVDs). Cardiovascular disease accounted for almost 800,000 deaths in the United States in 2017, according to the American Heart Association. In addition, cardiac attacks in the country are substantially prevalent. Every year, almost 790,000 U.S. adults have heart attacks. The majority of CVD deaths followed by a heart attack and stroke are caused by coronary heart disease. Such diseases are expected to produce high prevalence for the market to create profitable growth opportunities.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1297

Increasing Prevalence Of Hernia To Boost Market Growth

One of the key market drivers is also an increasing prevalence of hernia. Abdominal operation, heavy weight lifting, chronic coughing, constipation, ascites (abdominal fluid), and other conditions which increase pressure on the intra-abdominal region are major risk factors for herniation. In addition, nerve damage, tissue loss and genetic factors lead to muscle weakening. The residual embryological channel defects and the family history of the Congenital Hernia. In 2016, around 20 million inguinal hernia repair works were done annually throughout the world, according to an inquiry. There is therefore a chance that demand for these patches will increase significantly during the year after the wound recovery.

In Shorts

In 2018, the most important market share in soft tissue repair is expected to be seen throughout the forecast period, due to the growing prevalence of herniated cardiac repair, due to high prevalence of congenital heart disease and improving ePTFE segment treatments worldwide, but biomathic treatment represented the highest share of raw materials in 2018.

Asia Pacific Is Expected To Exhibit the Highest Growth Followed By North America Cardiovascular and Soft Tissue Repair Patches Market

Geographically, the global Cardiovascular and Soft Tissue Repair Patches market has been divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2018, Asia Pacific is expected to emerge in the fastest CAGR over the forecast time due to the rising prevalence of Congenital Heart Disease and Hernia, the highest share of North America's income due a high frequency of diseases and easy access of treatment alternatives. In Asia Pacific, China is one of the leading markets. Increasing concerns about early detection and prevention of congenital cardiac disease have led to the increase of different treatment options, such as cardiac patch implantation. The data published by the WHO estimate the annual rate of cardiovascular events that represent profitable market opportunities to rise by 50% between 2010 and 2030.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/cardiovascular-and-soft-tissue-repair-patches-market

Key Participants

The Cardiovascular & Soft Tissue Repair Patches market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are CryoLife, Edwards Life Sciences; Baxter; Admedus; Bard Peripheral Vascular, Inc; Cartiovascular Terumo: W.L. Gore & Associates; and Others.

One of the crucial factors that indicate the current market competitiveness is the increasing number of fusions and acquisitions by certain key players, such as Terumo Cardiovascular and Medtronic.

Browse All official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Cardiovascular & Soft Tissue Repair Patches
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Cardiovascular & Soft Tissue Repair Patches Market By Application
1.2.2.1. Global Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.2.2. Global Cardiovascular & Soft Tissue Repair Patches Market Revenue Share By Application in 2017
1.2.2.3. Vascular Repair & Reconstruction
1.2.2.4. Cardiac Repair
1.2.2.5. Pericardial Repair
1.2.2.6. Soft Tissue repair
1.2.2.7. Dural Repair
1.2.3. Cardiovascular & Soft Tissue Repair Patches Market By Raw Material
1.2.3.1. Global Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate Comparison By Raw Material (2015-2026)
1.2.3.2. ePTFE
1.2.3.3. Biomaterial and Tissue Engineered Material
1.2.3.4. Others
1.2.4. Cardiovascular & Soft Tissue Repair Patches Market by Geography
1.2.4.1. Global Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Cardiovascular & Soft Tissue Repair Patches Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Cardiovascular & Soft Tissue Repair Patches Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Cardiovascular & Soft Tissue Repair Patches Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Cardiovascular & Soft Tissue Repair Patches Major Manufacturers in 2017

CHAPTER 4. CARDIOVASCULAR & SOFT TISSUE REPAIR PATCHES MARKET BY APPLICATION

4.1. Global Cardiovascular & Soft Tissue Repair Patches Revenue By Application
4.2. Vascular Repair & Reconstruction
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Cardiac Repair
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Pericardial Repair
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Soft Tissue repair
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Dural Repair
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. CARDIOVASCULAR & SOFT TISSUE REPAIR PATCHES MARKET BY RAW MATERIAL

5.1. Global Cardiovascular & Soft Tissue Repair Patches Revenue By Raw Material
5.2. ePTFE
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Biomaterial and Tissue Engineered Material
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA CARDIOVASCULAR & SOFT TISSUE REPAIR PATCHES MARKET BY COUNTRY

6.1. North America Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Cardiovascular & Soft Tissue Repair Patches Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Cardiovascular & Soft Tissue Repair Patches Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE CARDIOVASCULAR & SOFT TISSUE REPAIR PATCHES MARKET BY COUNTRY

7.1. Europe Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Cardiovascular & Soft Tissue Repair Patches Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC CARDIOVASCULAR & SOFT TISSUE REPAIR PATCHES MARKET BY COUNTRY

8.1. Asia-Pacific Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Cardiovascular & Soft Tissue Repair Patches Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA CARDIOVASCULAR & SOFT TISSUE REPAIR PATCHES MARKET BY COUNTRY

9.1. Latin America Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Cardiovascular & Soft Tissue Repair Patches Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST CARDIOVASCULAR & SOFT TISSUE REPAIR PATCHES MARKET BY COUNTRY

10.1. Middle East Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Cardiovascular & Soft Tissue Repair Patches Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA CARDIOVASCULAR & SOFT TISSUE REPAIR PATCHES MARKET BY COUNTRY

11.1. Africa Cardiovascular & Soft Tissue Repair Patches Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Cardiovascular & Soft Tissue Repair Patches Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Raw Material, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. CryoLife
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Edwards Life Sciences
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Baxter
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Admedus
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Bard Peripheral Vascular, Inc
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Terumo Cardiovascular
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. W.L. Gore & Associates
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Others
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1297

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1297

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.